Deep transcranial magnetic stimulation for obsessive-compulsive disorder is efficacious even in patients who failed multiple medications and CBT

Yiftach Roth, Noam Barnea-Ygael, Lior Carmi, Eric A. Storch, Aron Tendler, Abraham Zangen

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

OCD is a chronic and disabling disease with a lifetime prevalence of 2%-3%. About 40–60% of these patients do not adequately respond to pharmacotherapy and CBT. Deep transcranial magnetic stimulation (dTMS) was shown to be safe and effective as a treatment alternative for OCD and recently received regulatory approvals. Yet it is unclear whether patients who failed numerous medications and/or CBT can still benefit from dTMS. Here, we analyzed recent data from a double-blind multicenter dTMS study and found efficacy of this novel treatment even in OCD patient cohorts who previously failed to respond to multiple medications and CBT.

Original languageEnglish
Article number113179
JournalPsychiatry Research
Volume290
DOIs
StatePublished - 1 Aug 2020

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Fingerprint

Dive into the research topics of 'Deep transcranial magnetic stimulation for obsessive-compulsive disorder is efficacious even in patients who failed multiple medications and CBT'. Together they form a unique fingerprint.

Cite this